<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Craniopharyngioma - Okell Surgery Notes</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="14-pyloric-stenosis.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 25%;"></div>
                        </div>
                       <span class="progress-text">Topic 15 of 60</span>
                    </div>
                    <a href="16-cryptorchidism.html" class="nav-button">
                        <span class="nav-text">Next: Cryptorchidism</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">CRANIOPHARYNGIOMA</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: overview -->
                <section id="overview" class="content-section">
                    <h2 class="section-heading">Overview</h2>
                    <div class="content-card">
                        <p><strong>Other names:</strong> Rathke pouch tumor, suprasellar cyst, pituitary epidermoid tumor, ameloblastoma pituitary adamantinoma</p>
                        
                        <h3>Definition</h3>
                        <p>Are histologically benign tumors that are found in the sella tursica and are composed of squamous epithelial cells.</p>

                        <h3>Origin</h3>
                        <p>The origin of these tumors is presumed to be from rests of embryonic tissue located in Rathke pouch, an embryonic structure that later forms the anterior pituitary gland.</p>

                        <h3>Age & Incidence</h3>
                        <p>These tumors may appear clinically at any age and constitute <strong>6 to 10%</strong> of all intracranial tumors in children.</p>
                        <p>Although craniopharyngiomas usually occur in the suprasellar region they may extend superiorly into the third ventricle, or inferiorly along the base of the brain.<br>
                        Usual course - progressive.</p>

                        <h3>Morbidity</h3>
                        <p>Although histologically benign, the clinical behavior of this tumour and its proximity to the optic chiasm, carotid arteries, third cranial nerve, and pituitary stalk, make this a difficult tumor to treat without morbidity.</p>
                    </div>
                </section>
                <!-- END: overview -->

                <!-- START: clinical-presentation -->
                <section id="clinical-presentation" class="content-section">
                    <h2 class="section-heading">Clinical Presentation</h2>
                    <div class="content-card">
                        <p>Most often the presenting complaints are secondary to central-nervous-system involvement by the tumor; they include headaches, vomiting, visual disturbances, symptoms of diabetes insipidus, and changes in sensorium.</p>
                        
                        <h4>Visual Disturbances</h4>
                        <ul class="enhanced-list">
                            <li>Bitemporal hemianopia (52%)</li>
                            <li>Significant unilateral visual acuity deficit (35%)</li>
                            <li>Papilledema (27%)</li>
                            <li>Homonymous hemianopia (8%)</li>
                            <li>Unilateral hemianopia (8%)</li>
                            <li>Bilateral visual acuity deficit</li>
                        </ul>

                        <h4>Endocrine & Hypothalamic Signs</h4>
                        <ul class="enhanced-list">
                            <li>In some patients there are no signs of endocrine deficiency; in others growth arrest and pubertal delay may be obvious features.</li>
                            <li>If the tumor invades the hypothalamus, signs of impaired vegetative function may occur. These include <strong>poikilothermia, hypersomnia, and obesity</strong>.</li>
                        </ul>

                        <h3>Anatomy</h3>
                        <p>The most common location of these tumors is a combination of intrasellar and suprasellar (70%).<br>
                        Twenty percent are only suprasellar, and 10% are purely intrasellar. These tumors occasionally grow into the third ventricle, causing hydrocephalus.<br>
                        The arterial supply is usually from the anterior cerebral and anterior communicating arteries or from the internal carotid and posterior communicating arteries.</p>
                    </div>
                </section>
                <!-- END: clinical-presentation -->

                <!-- START: investigations -->
                <section id="investigations" class="content-section">
                    <h2 class="section-heading">Investigations</h2>
                    <div class="content-card">
                        <h3>Laboratory</h3>
                        <p>A full pituitary endocrine workup is mandatory. Routine CBC count, chemistry panel, and coagulation studies are needed before surgery.</p>
                        <ul class="enhanced-list">
                            <li>Corticotropin (ACTH)</li>
                            <li>Growth hormone (GH) and insulin growth factor (IGF-1)</li>
                            <li>Cortisol</li>
                            <li>Prolactin</li>
                            <li>Luteinizing hormone (LH)</li>
                            <li>Follicle-stimulating hormone (FSH)</li>
                            <li>Thyrotropin (TSH)</li>
                            <li>Triiodothyronine (T3), Thyroxine (T4)</li>
                        </ul>

                        <h3>Imaging</h3>
                        <ol class="enhanced-list">
                            <li><strong>Skull x-ray:</strong> Because many as 88% of patients have <strong>suprasellar or intrasellar calcification</strong>. Even when calcification is not present there is often ballooning of the sella or erosion of the sella walls and posterior clinoid processes.</li>
                            <li><strong>CT-scan</strong></li>
                            <li><strong>MRI:</strong> Advantage over CT is that MRI can easily visualize the tumor in multiple planes and also give the surgeon a better view of the relationship of the tumor to the arteries of the Circle of Willis, pituitary stalk, and the optic and oculomotor nerves.</li>
                        </ol>
                    </div>
                </section>
                <!-- END: investigations -->

                <!-- START: management -->
                <section id="management" class="content-section">
                    <h2 class="section-heading">MANAGEMENT</h2>
                    <div class="content-card">
                        <p>Controversy exists with respect to the extent of surgical resection and the use of postoperative irradiation.</p>
                        <p>The ultimate goal is to prevent recurrence of the tumor with the least impairment of endocrine and intellectual function. These goals can be achieved either by complete surgical removal of the tumor, or by cyst drainage or partial resection followed by radiotherapy.</p>

                        <h3>Surgical Approaches</h3>
                        <ul class="enhanced-list">
                            <li><strong>Trans-sphenoidal approach:</strong> The surgeon approaches the sella turcica by a submucosal incision through the nose along the nasal septum approaching the pituitary fossa via the sphenoid sinus.</li>
                            <li><strong>Pterional craniotomy:</strong> The standard approach to suprasellar lesions because it allows good visualization of the optic nerves and chiasm. Variations have been proposed to include resection of the orbital rim and zygoma so as to provide a more basal view and therefore better access to the superior aspects of this tumor.</li>
                        </ul>

                        <h3>Outcome Considerations</h3>
                        <ul class="enhanced-list">
                            <li><strong>Complete surgical resection</strong> will obviate the need for irradiation, but such aggressive surgery usually results in permanent endocrine dysfunction and sometimes behavioral and intellectual abnormalities.</li>
                            <li><strong>Radiotherapy</strong> usually spares remaining endocrine dysfunction, but can cause intellectual problems, especially in the younger child.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: management -->

            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="14-pyloric-stenosis.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 25%;"></div>
                        </div>
                       <span class="progress-text">Topic 15 of 60</span>
                    </div>
                    <a href="16-cryptorchidism.html" class="nav-button">
                        <span class="nav-text">Next: Cryptorchidism</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>